Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Taguchi, Jun  [Clear All Filters]
Journal Article
Ishiyama K, Yamaguchi T, Eto T, Ohashi K, Uchida N, Kanamori H, Fukuda T, Miyamura K, Inoue Y, Taguchi J, et al. Acute megakaryoblastic leukemia, unlike acute erythroid leukemia, predicts an unfavorable outcome after allogeneic HSCT. Leuk Res. 2016;47:47-53.
Fujioka M, Itonaga H, Furumoto T, Sakaki C, Sakamoto H, Kato T, Horai M, Taguchi M, Sawayama Y, Taguchi J, et al. Clinical features of non-infectious pulmonary complications after donor lymphocyte infusion in post-transplant patients: The Nagasaki transplant group experience. Transpl Immunol. 2022:101707.
Sakamoto H, Itonaga H, Sawayama Y, Taguchi J, Saijo T, Kuwatsuka S, Hashisako M, Kinoshita N, Oishi M, Doi H, et al. Primary Oral Mucormycosis Due to Rhizopus microsporus after Allogeneic Stem Cell Transplantation. Intern Med. 2018;57(17):2567-2571.
Fujioka M, Itonaga H, Furumoto T, Kasai S, Sakamoto H, Kitanosono H, Kato T, Horai M, Sato S, Sawayama Y, et al. The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group Experience. Transpl Immunol. 2021:101417.
Taguchi M, Imaizumi Y, Taguchi J, Imanishi D, Sasaki D, Hasegawa H, Tsushima H, Hata T, Miyazaki Y. Transient proliferation of donor-derived ATL cell-like lymphocytes early after allogeneic stem cell transplantation in an adult T-cell leukemia/lymphoma patient. Blood. 2013;121(21):4428-4430.
Sakamoto H, Itonaga H, Sawayama Y, Furumoto T, Fujioka M, Chiwata M, Toriyama E, Kasai S, Nakashima J, Horai M, et al. Treatment with Mogamulizumab or Lenalidomide for Relapsed Adult T-cell Leukemia/Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation: The Nagasaki Transplant Group Experience. Hematol Oncol. 2020.